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and medical evidence that is put into practice. Although the Agency
for Healthcare Research and Quality (AHRQ) has a long history of
developing the content of evidence, the agency now pivots to close
that gap by focusing on evidence dissemination and implementa-
tion. Achieving better health outcomes requires both the generation
of new patient-centered outcomes research (PCOR) knowledge and
the appropriate and timely implementation of that knowledge into
practice. The Affordable Care Act provided funds to support both
types of PCOR efforts, with AHRQ building on years of experience to
advance research dissemination and implementation. This article
describes the work the AHRQ has done, is doing, and will do in the
future. To communicate PCOR evidence ﬁndings, AHRQ is currently
synthesizing research ﬁndings into convincing collections of evi-
dence that can be best taken up by clinicians, patients andee front matter Copyright & 2015, International S
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037.caregivers, and policymakers. The future direction for AHRQ is to
improve the context for evidence and practice improvement, thereby
creating an environment receptive to PCOR. Toward this goal, AHRQ
is actively engaging partners, such as professional societies and
insurers, to make evidence central to decision making. In addition,
AHRQ recently launched two programs that seek to both understand
and encourage the use of evidence in clinical practice. Throughout
these efforts, AHRQ will continually assess needs and adapt initia-
tives to ensure that PCOR translates into improved patient-centered
health outcomes.
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yet the gap grows between what is known and what is put into
practice. Occasionally, the medical community quickly adopts new
research, particularly where demonstrable harm exists—as in using
hormone replacement therapy for the prevention of cardiovascular
disease [1]. Other times, it can take years even for compelling
evidence to saturate clinical practice, as with beta-blockers after
myocardial infarction [2]. Financial incentives, differing interpreta-
tions of results, cognitive biases, and inadequate use of clinical
decision support have all been posited as reasons why research
studies fail to change practice [3]. Patient-centered outcomes
research (PCOR) evidence generation is necessary but not sufﬁcient
to produce what patients care most about—better health outcomes.
Evidence needs to be put into practice.
Recognizing the need, the Affordable Care Act (ACA) provided
funds, which are now approximately $100 million per year, to the
Agency for Healthcare Research and Quality (AHRQ) to dissem-
inate and implement PCOR evidence, in addition to a directive to
train researchers. This AHRQ work is in collaboration with the
two other components of the ACA PCOR portfolio—the Patient-
Centered Outcomes Research Institute’s broad mandate to aidpatients in health-related decision making by advancing the
quality and relevance of evidence, and the provision for the
Secretary of Health and Human Services to develop data infra-
structure for conducting PCOR. Although the ACA funding is new,
AHRQ builds on years of experience in both generating new
knowledge and facilitating research ﬁnding uptake, which ﬁts
within a framework of three factors: content of evidence, com-
munication of the ﬁndings, and context for evidence and practice
improvement. Improving the context for evidence and practice
improvement by enhancing the receptivity of payers and pro-
viders to evidence is a focus for AHRQ. This article highlights the
work that AHRQ has done, is doing, and will do in the future to
improve the uptake of PCOR ﬁndings.Content of Evidence
For many years, AHRQ has been a leading funder of studies that
have closed many gaps in medical knowledge. AHRQ-funded
research has shed light on topics ranging from the treatment of
non–small cell lung cancer [4] to the safety of attention deﬁcit/ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 3 5 5 – 3 5 7356hyperactivity disorder drugs [5,6] to the optimal duration of
antiplatelet therapy after percutaneous coronary intervention
[7]. AHRQ recognizes that the baton of PCOR evidence generation
is now passed to the Patient-Centered Outcomes Research Insti-
tute whose mandate is to continue and expand this primary
comparative clinical effectiveness research, along with the long-
standing and ongoing commitment of the National Institutes of
Health to generate clinical evidence. In the PCOR evidence arena,
AHRQ now pivots to improving evidence dissemination and
implementation.Communication of Findings
A critical ﬁrst step in communicating PCOR ﬁndings is organizing
the vast and sometimes disparate primary research publications
into collections of PCOR evidence. Synthesizing a body of work,
rather than just presenting individual studies, enhances commu-
nication by demonstrating reproducibility and providing insights
into how the ﬁndings will apply to diverse real-world patients.
AHRQ has established a successful record of enhancing the
content of medical knowledge by generating authoritative synthe-
ses of research evidence through the Evidence-based Practice
Center (EPC) Program [8]. The impact of the EPC Program has
ranged, for example, from two evidence reports on diabetes care
contributing to the evidence base for nearly 20 guidelines in the
National Guideline Clearinghouse, to being a key factor in the Food
and Drug Administration ban of ephedra-containing supplements.
The AHRQ-funded John M. Eisenberg Center for Clinical Deci-
sions and Communications Science transforms these comprehen-
sive evidence syntheses into concise, practically applicable
summaries tailored for clinicians, patients and caregivers, and
policymakers. AHRQ has produced more than 100 of these trans-
lational products through its Effective Health Care (EHC) Program,
as well as generating free continuing education modules, slide sets
for academic instruction, interactive decision aids for patients, and
archived Webcasts. More than 5 million EHC Program publications
have been distributed, and more than 60,000 health professionals
have earned continuing education credit by completing activities
based on EHC Program resources. The overall goal of these efforts
is to bring both the patient and the physician closer to the
evidence by providing succinct, accessible summaries that facili-
tate informed shared decision making.Context for Evidence and Practice Improvement
The context for evidence and practice improvement is the
environment in which the information will land to affect change.
Contextual elements include the beliefs, values, and preferences
of patients and physicians, as well as ﬁnancial incentives and the
structure of health care delivery. Context is the most challenging
of the three factors to inﬂuence and the one in which AHRQ has
the fewest direct levers to drive change on its own. Establishing
an environment receptive to PCOR is a critical need and one in
which AHRQ, expanding on previous work, will focus much of its
PCOR implementation efforts in the next several years.
In providing the evidence, AHRQ actively promotes PCOR
evidence to health system partners, such as professional soci-
eties in their educational and clinical guidelines activities, the
Centers for Medicare & Medicaid Services and private payers in
their coverage decisions, and health care providers in integrating
evidence into the fabric of care delivery. For instance, the EPC
Program drives implementation by identifying partners, such as
medical professional societies or provider organizations, who use
the reports to generate clinical guidelines, establish research
agendas, and develop quality measures. One such successfulevidence implementation was the series of EPC Program evidence
reports and AHRQ studies on the use of atypical antipsychotic
medications that contributed through active partnerships to
Maryland developing a medication peer-review program and to
new National Committee for Quality Assurance Healthcare Effec-
tiveness Data and Information Set performance measures, all
focused on promoting and assessing safe and appropriate anti-
psychotic medication use in children and adolescents. As a
second example, the results of an EPC Program report were an
important factor in an Ofﬁce of Personnel Management decision
to encourage Federal Employees Health Beneﬁt plans to include
Applied Behavioral Analysis as a covered beneﬁt for children with
autism. Future EPC Program work will similarly be produced with
speciﬁc implementation paths.
To enhance the ability of providers to implement ﬁndings into
practice, AHRQ recently launched two programs. The “Accelerat-
ing the Dissemination and Implementation of PCOR Findings into
Primary Care Practice” initiative [9], with funding of up to $45
million per year over 3 years, uses PCOR ﬁndings to prevent
cardiovascular disease in alignment with the Million Hearts
campaign through improving the use of aspirin in high-risk
individuals, blood pressure and cholesterol control, and smoking
cessation. This program also strengthens the underlying
decision-making context for small and medium-sized primary
care practices by developing the capacity and infrastructure to
implement PCOR ﬁndings in an ongoing basis. A second initia-
tive, “Comparative Health System Performance in Accelerating
PCOR Dissemination” [10], provides up to $10.5 million per year
for 5 years creating Centers of Excellence to understand the role
of health systems and their characteristics in the uptake of PCOR
ﬁndings and the quality and cost of care. In today’s complex and
quickly changing health care delivery environment, this program
aims to provide researchers, payers, system leaders, and others
the evidence they need to improve systems’ uptake of PCOR
ﬁndings.The Path Forward
Both the medical community and AHRQ have for years recog-
nized the need to bring research evidence into practice. PCOR
implementation requires a multifaceted approach addressing the
content of evidence, the communication approach, and the
context in which that evidence will be received. AHRQ will
continually assess needs and develop new initiatives to ensure
that PCOR translates into improved patient-centered health
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